Safety and Efficacy of HB-1 for Post-Traumatic Stress Disorder
Clinical trial NCT07499440 · RECRUITING
Trial details
- NCT number
- NCT07499440
- Sponsor
- HB BioTech, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.